$ Value
$0
Shares
540,000
Price
$0
Filed
May 20
Insider
Name
MCCOURT Thomas A
Title
Chief Executive Officer
CIK
0001478448
Roles
Transaction Details
Transaction Date
2025-05-20
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,687,281
Footnotes
The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person. | The restricted stock unit award, granted as an annual performance award, vests as to 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.
Filing Info
MCCOURT Thomas A's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-10 | IRWD | A | $0 |
| 2026-02-24 | IRWD | ▼ | $379K |
| 2026-02-23 | IRWD | ▼ | $361K |
| 2025-06-05 | PLRX | A | $0 |
| 2025-05-20 | IRWD | A | $0 |
| 2025-05-16 | IRWD | ▼ | $8K |
Other Insiders at IRWD (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| DENNER ALEXANDER J | — | $20.5M | 2026-03-17 |
|
MCCOURT Thomas A
Chief Executive Officer
|
— | $740K | 2026-03-10 |
|
Shetzline Michael
SVP, CMO, Head-Res&Drug
|
— | $122K | 2026-03-10 |
|
Silver Ronald
Principal Accounting Officer
|
— | $90K | 2026-03-10 |
|
John Minardo
Chief Legal Officer
|
— | $136K | 2026-03-10 |
|
Martini Gregory S.
Chief Financial Officer
|
— | $82K | 2026-03-10 |
|
Gaskins Tammi L
Chief Commercial Officer
|
— | $80K | 2026-03-10 |